Randall Division of Cell and Molecular Biophysics, King's College London, London, UK.
Bioessays. 2010 Nov;32(11):986-92. doi: 10.1002/bies.201000060. Epub 2010 Sep 10.
Rnd3/RhoE has two distinct functions, regulating the actin cytoskeleton and cell proliferation. This might explain why its expression is often altered in cancer and by multiple stimuli during development and disease. Rnd3 together with its relatives Rnd1 and Rnd2 are atypical members of the Rho GTPase family in that they do not hydrolyse GTP. Rnd3 and Rnd1 both antagonise RhoA/ROCK-mediated actomyosin contractility, thereby regulating cell migration, smooth muscle contractility and neurite extension. In addition, Rnd3 has been shown to have a separate role in inhibiting cell cycle progression by reducing translation of cell cycle regulators, including cyclin D1 and Myc. We propose that Rnd3 could act as a tumour suppressor to limit proliferation, but when mutations bypass this activity of Rnd3, it can promote cancer invasion through its effects in the actin cytoskeleton.
Rnd3/RhoE 具有两种不同的功能,调节肌动蛋白细胞骨架和细胞增殖。这可能解释了为什么其表达在癌症中经常发生改变,并且在发育和疾病过程中受到多种刺激的影响。Rnd3 与其同源物 Rnd1 和 Rnd2 一起是非典型的 Rho GTPase 家族成员,因为它们不能水解 GTP。Rnd3 和 Rnd1 都拮抗 RhoA/ROCK 介导的肌动球蛋白收缩性,从而调节细胞迁移、平滑肌收缩和神经突延伸。此外,已经表明 Rnd3 通过减少细胞周期调节剂(包括细胞周期蛋白 D1 和 Myc)的翻译来发挥抑制细胞周期进程的单独作用。我们提出 Rnd3 可以作为肿瘤抑制因子来限制增殖,但是当突变绕过 Rnd3 的这种活性时,它可以通过其在肌动蛋白细胞骨架中的作用促进癌症侵袭。